Akoya Biosciences Inc (NASDAQ: AKYA) is -47.75% lower on its value in year-to-date trading and has touched a low of $1.88 and a high of $6.31 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AKYA stock was last observed hovering at around $2.64 in the last trading session, with the day’s loss setting it -0.09%.
Currently trading at $2.55, the stock is 10.39% and 9.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.15 million and changing -3.41% at the moment leaves the stock -33.55% off its SMA200. AKYA registered -51.43% loss for a year compared to 6-month loss of -57.71%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 9.91% gain in the last 1 month and extending the period to 3 months gives it a 18.60%, and is -1.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.03% over the week and 7.84% over the month.
Akoya Biosciences Inc (AKYA) has around 330 employees, a market worth around $126.22M and $93.22M in sales. Profit margin for the company is -64.74%. Distance from 52-week low is 35.64% and -59.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-58.24%).
The EPS is expected to grow by 29.22% this year.
Akoya Biosciences Inc (AKYA) Top Institutional Holders
90.0 institutions hold shares in Akoya Biosciences Inc (AKYA), with institutional investors hold 75.77% of the company’s shares. The shares outstanding are 49.12M, and float is at 22.18M with Short Float at 15.14%. Institutions hold 67.17% of the Float.
The top institutional shareholder in the company is BLUE WATER LIFE SCIENCE ADVISORS, LP with over 4.7 million shares valued at $10.99 million. The investor’s holdings represent 9.5506% of the AKYA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 1.5 million shares valued at $$3.51 million to account for 3.0534 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.46 million shares representing 2.976% and valued at over $3.43 million, while GEODE CAPITAL MANAGEMENT, LLC holds 1.1428 of the shares totaling 0.56 million with a market value of $1.32 million.
Akoya Biosciences Inc (AKYA) Insider Activity
The most recent transaction is an insider sale by McKelligon Brian,the company’sPresident and CEO. SEC filings show that McKelligon Brian sold 7,500 shares of the company’s common stock on Jun 11 ’24 at a price of $2.08 per share for a total of $15630.0. Following the sale, the insider now owns 0.22 million shares.
Akoya Biosciences Inc disclosed in a document filed with the SEC on Jun 06 ’24 that McKelligon Brian (President and CEO) sold a total of 7,500 shares of the company’s common stock. The trade occurred on Jun 06 ’24 and was made at $2.01 per share for $15064.0. Following the transaction, the insider now directly holds 0.22 million shares of the AKYA stock.
Still, SEC filings show that on Mar 20 ’24, McKelligon Brian (President and CEO) disposed off 7,500 shares at an average price of $4.97 for $37243.0. The insider now directly holds 231,868 shares of Akoya Biosciences Inc (AKYA).
